Back to search

Poland· PL-100421550

Rosuvastatin/Amlodipine Teva

A rosuvastatin und amlodipin product containing rosuvastatinum + amlodipinum, registered in Poland by Teva B.V.. The same ATC class is registered in 5 of our 19 countries.

ATC C10BX09

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedRosuvastatin/Amlodipine TevaATCC10BX09REGISTER NO.PL-100421550PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Rosuvastatin und amlodipin is registered in 5 of 19 countries.

Countries holding a registration under ATC C10BX09 (rosuvastatin und amlodipin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Rosuvastatin und amlodipin · ATC C10BX09

5 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Rosuvastatinum + Amlodipinum
Manufacturer
Teva B.V.
Country
Poland (PL)
ATC code
C10BX09
ATC class
Rosuvastatin und Amlodipin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991465759
  • gtin
    05909991465766
  • gtin
    05909991465735
  • gtin
    05909991465742

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rosuvastatin und amlodipin in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rosuvastatin und amlodipin products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Bulgaria · Тинтарос Ам
  • Germany · Rosuamlo Apontis, Rosulod
  • Spain · Rosuvastatina/Amlodipino Aristo
  • Italy · Coaredam, Rosulod
  • Portugal · Asutam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1b77f94a-b93b-46b1-a71e-c279f01f5e03
GET /v1/drugs/1b77f94a-b93b-46b1-a71e-c279f01f5e03?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "10 mg + 5 mg",
  "packaging": "05909991465735 ¦ Rp ¦ 141926\n100 kaps.\n05909991465742 ¦ Rp ¦ 141927\n10 kaps.\n05909991465759 ¦ Rp ¦ 141928\n30 kaps.\n05909991465766 ¦ Rp ¦ 141929\n28 kaps.",
  "substance": "Rosuvastatinum 10 mg + Amlodipinum 5 mg",
  "common_name": "Rosuvastatinum + Amlodipinum",
  "pl_product_id": "100421550",
  "pozwolenie_nr": "26643",
  "auth_procedure": "DCP",
  "authorisation_validity": "2026-09-30"
}

See everything about rosuvastatin und amlodipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.